Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $73K 1,045 sh | Jan 16, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $56K 120 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $168K 360 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $30K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $110K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $145K 320 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $108K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $186K 400 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 12 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $209K 1,010 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 11 | Burroughs Amy L.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $282K 7,521 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Cummings MarthaDirector | Open-market sale · 10b5-1 plan | SELL | $13K 2,853 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $37K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $38K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $37K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $37K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $38K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Hettrich KevinCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $104K 9,800 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Jarboe Scott T.CAO and Corporate Secretary | Open-market sale · 10b5-1 plan | SELL | $74K 2,151 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 8 | Scott JacobGENERAL COUNSEL AND CORP. SEC. | Open-market sale · 10b5-1 plan | SELL | $154K 21.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $125K 600 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 8 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $14K 200 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 6 | Sumner CrystalSee Remarks | Open-market sale · 10b5-1 plan | SELL | $22K 5,055 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $479K 11.5K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.7K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $383K 9,258 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $286K 7,046 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $348K 8,467 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $533K 13.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 1 | Peer AndrewVP, Corporate Controller & CAO | Open-market sale · 10b5-1 plan | SELL | $15K 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 44 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Open-market sale | SELL | $2.87M 100.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 40 | Saintil MerlineDirector | Open-market sale · 10b5-1 plan | SELL | $8.31M 96.0K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 38 | Donohoe Bryan PatrickChief Executive Officer | Open-market sale | SELL | $107K 21.8K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 36 | Tkach CameronExecutive Vice President, COO | Open-market sale | SELL | $3,664 745 sh | Jan 15, 2026 traded Jan 2, 2025 |
| 35 | Gonzales Jeffrey MichaelCFO and Treasurer | Open-market sale | SELL | $31K 6,218 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 35 | Feingold AntonGen. Counsel VP and Secretary | Open-market sale | SELL | $37K 7,606 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 34 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Open-market sale | SELL | $107K 3,822 sh | Jan 15, 2026 traded Jan 13, 2026 |